Hosel K, Chasan B, Tode J, Rose-John S, Roider J, Ehlken C
J Ophthalmic Inflamm Infect. 2024; 14(1):57.
PMID: 39497001
PMC: 11535092.
DOI: 10.1186/s12348-024-00441-x.
Iannone C, Marelli L, Costi S, Pellico M, La Franca L, Caporali R
Children (Basel). 2023; 10(3).
PMID: 36979992
PMC: 10047268.
DOI: 10.3390/children10030434.
Thomas J, Kuthyar S, Shantha J, Angeles-Han S, Yeh S
Ann Eye Sci. 2021; 6.
PMID: 34131629
PMC: 8202723.
DOI: 10.21037/aes-2019-dmu-10.
Adrovic A, Yildiz M, Koker O, Sahin S, Barut K, Kasapcopur O
Arch Rheumatol. 2021; 36(1):146-157.
PMID: 34046584
PMC: 8140868.
DOI: 10.46497/ArchRheumatol.2021.7953.
Kim L, Li A, Angeles-Han S, Yeh S, Shantha J
Expert Rev Ophthalmol. 2020; 14(4-5):211-218.
PMID: 32831897
PMC: 7437956.
DOI: 10.1080/17469899.2019.1663731.
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Gaggiano C, Rigante D, Tosi G, Vitale A, Frediani B, Grosso S
Clin Rheumatol. 2019; 39(2):327-337.
PMID: 31823144
DOI: 10.1007/s10067-019-04763-3.
Interleukin-6 inhibition in the management of non-infectious uveitis and beyond.
Karkhur S, Hasanreisoglu M, Vigil E, Halim M, Hassan M, Plaza C
J Ophthalmic Inflamm Infect. 2019; 9(1):17.
PMID: 31523783
PMC: 6745304.
DOI: 10.1186/s12348-019-0182-y.
Optimising drug therapy for non-infectious uveitis.
Shahab M, Mir T, Zafar S
Int Ophthalmol. 2018; 39(7):1633-1650.
PMID: 29961190
DOI: 10.1007/s10792-018-0984-1.
Management of Uveitis in Spondyloarthropathy: Current Trends.
Gupta N, Agarwal A
Perm J. 2017; 22:17-041.
PMID: 29272246
PMC: 5741284.
DOI: 10.7812/TPP/17-041.
An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.
Sood A, Angeles-Han S
Curr Treatm Opt Rheumatol. 2017; 3(1):1-16.
PMID: 28944162
PMC: 5604477.
DOI: 10.1007/s40674-017-0057-z.
IL-6 blockade in the management of non-infectious uveitis.
Lopalco G, Fabiani C, Sota J, Lucherini O, Tosi G, Frediani B
Clin Rheumatol. 2017; 36(7):1459-1469.
PMID: 28528519
DOI: 10.1007/s10067-017-3672-z.
A review and update on orphan drugs for the treatment of noninfectious uveitis.
You C, Sahawneh H, Ma L, Kubaisi B, Schmidt A, Foster C
Clin Ophthalmol. 2017; 11:257-265.
PMID: 28203051
PMC: 5298311.
DOI: 10.2147/OPTH.S121734.
Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Oray M, Tugal-Tutkun I
Turk J Ophthalmol. 2016; 46(2):77-82.
PMID: 27800265
PMC: 5082254.
DOI: 10.4274/tjo.09581.
[Treatment of posterior noninfectious uveitis : Current situation and future developments].
Pleyer U, Pohlmann D, Stubiger N
Ophthalmologe. 2016; 113(5):380-90.
PMID: 27165275
DOI: 10.1007/s00347-016-0267-z.
[Immunomodulatory therapy of autoimmune diseases : Quo vadis?].
Hoyer B, Hiepe F
Ophthalmologe. 2016; 113(5):373-9.
PMID: 27155599
DOI: 10.1007/s00347-016-0263-3.
[Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
Heiligenhaus A, Tappeiner C, Walscheid K, Heinz C
Ophthalmologe. 2016; 113(5):391-7.
PMID: 27142035
DOI: 10.1007/s00347-016-0262-4.
Juvenile idiopathic arthritis-associated uveitis.
Clarke S, Sen E, Ramanan A
Pediatr Rheumatol Online J. 2016; 14(1):27.
PMID: 27121190
PMC: 4848803.
DOI: 10.1186/s12969-016-0088-2.
Drug discovery in ophthalmology: past success, present challenges, and future opportunities.
Gower N, Barry R, Edmunds M, Titcomb L, Denniston A
BMC Ophthalmol. 2016; 16:11.
PMID: 26774505
PMC: 4715274.
DOI: 10.1186/s12886-016-0188-2.
Targeting interleukin-6 for noninfectious uveitis.
Lin P
Clin Ophthalmol. 2015; 9:1697-702.
PMID: 26392750
PMC: 4574854.
DOI: 10.2147/OPTH.S68595.
The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
Lerman M, Rabinovich C
Paediatr Drugs. 2015; 17(4):283-301.
PMID: 25893479
PMC: 4627498.
DOI: 10.1007/s40272-015-0128-2.
